Two recently published Phase II studies demonstrated the safety and performance of Versiva XC Gelling Foam Dressings as part of a protocol of care in promoting wound healing by managing exudate, protecting the surrounding skin and minimizing patient discomfort.
Nino Pionati, senior vice president of global marketing and business development, ConvaTec US Wound Therapeutics, said: “In addition to protecting periwound skin and supporting healing, Versiva XC also cushion and protect, thereby increasing patient comfort at the time of dressing removal.”